Author:
van Wijk Marja J,Maas D Willemijn,Renders Nicole HM,Hermans Mirjam HA,Zaaijer Hans L,Hogema Boris M
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. ECDC: Risk assessment on Q fever. 2010, Stockholm, http://www.ecdc.europa.eu/en/publications/Publications/1005_TER_Risk_Assessment_Qfever.pdf , ISBN 978-92-9193-210-8,
2. Kampschreur LM, Dekker S, Hagenaars JCJP, Lestrade PJ, Renders NHM, De Jager-Leclercq MGL, Hermans MHA, Groot CAR, Groenewold RHH, Hoepelman AIM, Wever PC, Oosterheert JJ: Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis. 2012, 18: 563-570.
3. Raoult D, Houpikian P, Dupont H, Riss J, Arditi-Djiane JJ, Brouqui P: Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or Hydroxychloroquine. Arch Intern Med. 1999, 159 (2): 167-173. 10.1001/archinte.159.2.167.
4. Raoult D, Marrie T: Q fever. Clin Infect Dis. 1995, 20: 489-496. 10.1093/clinids/20.3.489.
5. Kanfer E, Farrag N, Price C, MacDonald D, Coleman J, Barrett AJ: Q fever following bone marrow transplantation. Bone Marrow Transplant. 1988, 3: 165-166.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献